Tenax Therapeutics Insider Trades

TENX

Track insider trading activity from Tenax Therapeutics executives and directors. See which insiders are buying and selling TENX stock.

Trades Last 12 Months

TENX Price

All Insider Trades for Tenax Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Doogan Declan Director
Holding Value $99.5k 55,274 shares
Last Trade
Sep 16, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$102k 53,000 shares
$1.92
$1.80
Holding Value $39.9k 22,174 shares
Last Trade
Sep 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.83k 4,850 shares
$1.82
$1.80
Staab Thomas R Ii Chief Financial Officer
Holding Value $28.2k 15,675 shares
Last Trade
Sep 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11k 5,675 shares
$1.94
$1.80
Holding Value $11.7M 6,524,151 shares
Last Trade
Sep 03, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.6M 900,000 shares
$1.78
$1.80
Mcgauley Thomas Interim CFO
Holding Value $90k 50,000 shares
Last Trade
Jan 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 50,000 shares
$12.51
$1.80
Proehl Gerald T Director
Holding Value $54k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.9k 3,000 shares
$13.30
$1.80
Holding Value $54k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 30,000 shares
$13.30
$1.80
Holding Value $54k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 30,000 shares
$13.30
$1.80
Rich Stuart Chief Medical Officer
Holding Value $450k 250,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.33M 250,000 shares
$13.30
$1.80
Hunter Robyn Director
Holding Value $54k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 30,000 shares
$13.30
$1.80
Boyd Steven Director
Holding Value $0 0 shares
Last Trade
May 18, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.24B 2,072,538 shares
$1,081.28
$1.80
Holding Value $0 0 shares
Last Trade
Jul 14, 2021 Sale
$768M 250,000 shares
$3,072.00
$1.80
Holding Value $8.59M 4,773,269 shares
Last Trade
Jul 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.1B 4,773,269 shares
$3,168.00
$1.80
Holding Value $90k 50,000 shares
Last Trade
Jul 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158M 50,000 shares
$3,168.00
$1.80
Mitchum James P. Director
Holding Value $9k 5,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.8M 5,000 shares
$3,360.00
$1.80
Holding Value $126k 70,000 shares
Last Trade
Jan 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$207M 70,000 shares
$2,960.00
$1.80
Blanck Ronald R Director
Holding Value $10.9k 6,062 shares
Last Trade
May 18, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.16M 5,000 shares
$1,632.00
$1.80
Rallis Chris A Director
Holding Value $900 500 shares
Last Trade
May 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$502k 500 shares
$1,004.64
$1.80
Kelley John P Chief Executive Officer
Holding Value $2.31M 1,282,932 shares
Last Trade
Mar 15, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.12B 96,999 shares
$21,878.40
$1.80
Holding Value $63.4k 35,200 shares
Last Trade
May 01, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.3M 25,391 shares
$720.00
$1.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up